GENELUX CORP
GNLX · NASDAQ
Updated at 2026-10-14 09:17:16
- Today's High
- $2.54
- Today’s Low
- $2.48
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.59
- Previous Close
- $2.54
- Volume
- 72.61K
- Market Cap
- $115.14M
- P/E Ratio
- --
- EPS
- $-0.86
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2625 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA, UNITED STATES, 91361
- Country
- US
- Listing Date
- 2023-01-26
- Fiscal Year End
- December
- Shares Outstanding
- 44.84M
- CIK
- 0001231457
- Website
- genelux.com
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The company is headquartered in Westlake Village, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$8K
2025-09-30
$0
Operating Expenses
2026-06-30
$9.64M
2026-03-31
$8.36M
2025-12-31
$9.27M
2025-09-30
$8.19M
Net Income
2026-06-30
-$9.47M
2026-03-31
-$7.12M
2025-12-31
-$9.24M
2025-09-30
-$7.95M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
-115.58K%
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.21
2026-03-31
$-0.20
2025-12-31
$-0.24
2025-09-30
$-0.21
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$9.46M
2026-03-31
-$7.02M
2025-12-31
-$9.84M
2025-09-30
-$7.8M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $8K | $0 |
| Operating Expenses | $9.64M | $8.36M | $9.27M | $8.19M |
| Net Income | -$9.47M | -$7.12M | -$9.24M | -$7.95M |
| Net Profit Margin | -- | -- | -115.58K% | -- |
| Earnings Per Share | $-0.21 | $-0.20 | $-0.24 | $-0.21 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$9.46M | -$7.02M | -$9.84M | -$7.8M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.